BEIJING: Clinical trials of the United States biotech company Gilead Sciences’ experimental drug Remdesivir have begun in Wuhan, Hubei province, the centre of the novel coronavirus outbreak.
Experts hope this drug, along with others that have shown to be effective against the virus in test tubes, can also work well in actual human patients.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!